Edition:
United Kingdom

Zhejiang ChiMin Pharmaceutical Co Ltd (603222.SS)

603222.SS on Shanghai Stock Exchange

15.10CNY
15 Dec 2017
Change (% chg)

¥0.15 (+1.00%)
Prev Close
¥14.95
Open
¥14.90
Day's High
¥15.30
Day's Low
¥14.86
Volume
2,129,055
Avg. Vol
3,335,518
52-wk High
¥20.26
52-wk Low
¥13.79

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 166.21 0.062
Jun '17 151.11 0.035
Mar '17 133.23 0.027
FY 2016 Dec '16 121.41 0.048
Sep '16 121.01 0.040
Jun '16 105.41 0.019
Mar '16 102.56 0.021
FY 2015 Dec '15 103.20 0.040
Sep '15 121.61 0.052
Jun '15 110.19 0.035
Mar '15 113.60 0.040
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 116.29 32.14 32.93
P/E High - Last 5 Yrs. 145.71 40.81 45.62
P/E Low - Last 5 Yrs. 113.97 20.30 24.34
Beta -- 0.79 0.88
Price to Sales (TTM) 10.61 7.47 5.40
Price to Book (MRQ) 7.35 13.30 5.38
Price to Tangible Book (MRQ) 14.66 25.48 6.78
Price to Cash Flow (TTM) -- 21.76 23.45
% Owned Institutions -- 3.27 1.40

Dividends

  Company industry sector
Dividend Yield 0.23 1.02 1.50
Dividend Yield - 5 Year Avg -- 1.20 1.52
Dividend 5 Year Growth Rate -- 17.03 5.17
Payout Ratio(TTM) 26.63 29.72 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 43.35 8.52 9.00
Sales (TTM) vs TTM 1 Yr. Ago 21.71 1.89 5.38
Sales - 5 Yr. Growth Rate -3.86 8.72 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 88.35 51.48 19.67
EPS (TTM) vs TTM 1 Yr. Ago 13.97 -- --
EPS - 5 Yr. Growth Rate -14.96 19.69 10.79
Capital Spending - 5 Yr. Growth Rate 30.17 8.56 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.45 2.40 2.18
Current Ratio (MRQ) 1.85 3.15 2.98
LT Debt to Equity (MRQ) 20.82 29.52 11.56
Total Debt to Equity (MRQ) 36.78 35.99 15.81
Interest Coverage (TTM) -- 16.05 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 43.45 58.76 54.83
Gross Margin - 5 Yr. Avg. 47.89 58.51 52.40
EBITD Margin (TTM) 11.93 -- --
EBITD - 5 Yr. Avg 20.00 23.44 15.24
Operating Margin (TTM) 11.19 17.92 7.76
Operating Margin - 5 Yr. Avg. 13.95 16.28 10.75
Pre-Tax Margin (TTM) 11.22 17.70 8.57
Pre-Tax Margin - 5 Yr. Avg. 14.04 16.57 11.17
Net Profit Margin (TTM) 9.18 13.59 4.88
Net Profit Margin - 5 Yr. Avg. 12.05 11.61 7.47
Effective Tax Rate (TTM) 18.18 22.86 23.11
Effective Tax Rate - 5 Yr. Avg. 14.20 29.05 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 470,730 27,388,617 864,680,848
Net Income/Employee (TTM) 43,221 3,271,870 101,718,394
Receivable Turnover (TTM) 3.60 5.05 5.76
Inventory Turnover (TTM) 3.52 3.14 3.34
Asset Turnover (TTM) 0.49 0.78 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.47 10.55 11.00
Return on Assets - 5 Yr. Avg. 8.31 9.14 12.43
Return on Investment (TTM) 5.74 14.01 14.46
Return on Investment - 5 Yr. Avg. 11.38 11.83 16.28
Return on Equity (TTM) 6.48 16.85 16.05
Return on Equity - 5 Yr. Avg. 11.55 14.12 17.51
  1 Year 3 Year 5 Year
Sales % 0.40 -6.97 -3.86
EPS (TTM) % -24.83 -27.73 -14.96
Dividend % -38.46 -- --
Note: Units in Millions of US Dollars

Performance for Zhejiang ChiMin Pharmaceutical Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.56%
# of Holders: 4
Total Shares Held: 1,800,537
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.